Impax Asset Management Group plc Acquires 135,198 Shares of Synopsys, Inc. $SNPS

Impax Asset Management Group plc boosted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 28.0% during the 2nd quarter, Holdings Channel reports. The firm owned 618,415 shares of the semiconductor company’s stock after buying an additional 135,198 shares during the period. Synopsys comprises about 1.8% of Impax Asset Management Group plc’s portfolio, making the stock its 11th biggest holding. Impax Asset Management Group plc’s holdings in Synopsys were worth $315,663,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Hemington Wealth Management raised its position in shares of Synopsys by 10.1% during the second quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after buying an additional 18 shares during the last quarter. Concord Asset Management LLC VA grew its stake in Synopsys by 0.8% during the second quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock valued at $1,220,000 after acquiring an additional 18 shares in the last quarter. Rehmann Capital Advisory Group grew its stake in Synopsys by 1.4% during the second quarter. Rehmann Capital Advisory Group now owns 1,345 shares of the semiconductor company’s stock valued at $690,000 after acquiring an additional 18 shares in the last quarter. MCF Advisors LLC increased its holdings in Synopsys by 16.2% in the 2nd quarter. MCF Advisors LLC now owns 136 shares of the semiconductor company’s stock valued at $70,000 after acquiring an additional 19 shares during the last quarter. Finally, Savvy Advisors Inc. lifted its stake in Synopsys by 3.6% in the 2nd quarter. Savvy Advisors Inc. now owns 551 shares of the semiconductor company’s stock worth $282,000 after purchasing an additional 19 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys Stock Up 0.8%

Shares of SNPS opened at $398.81 on Thursday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. The business has a fifty day moving average of $463.30 and a 200 day moving average of $514.08. The company has a market cap of $74.08 billion, a PE ratio of 31.30, a P/E/G ratio of 5.02 and a beta of 1.10. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). The firm had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The company’s revenue was up 14.0% compared to the same quarter last year. During the same period in the prior year, the company posted $3.43 EPS. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, sell-side analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Activity

In other news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the sale, the chief executive officer directly owned 71,615 shares in the company, valued at approximately $42,181,951.15. This represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Robert G. Painter acquired 350 shares of the company’s stock in a transaction that occurred on Thursday, September 11th. The shares were acquired at an average price of $425.44 per share, with a total value of $148,904.00. Following the acquisition, the director owned 2,291 shares in the company, valued at $974,683.04. This trade represents a 18.03% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders sold 30,894 shares of company stock worth $16,760,783 in the last ninety days. 0.62% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

SNPS has been the subject of a number of research analyst reports. BNP Paribas assumed coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective for the company. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. JPMorgan Chase & Co. reduced their price objective on Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Rosenblatt Securities reiterated a “neutral” rating and set a $605.00 target price (down from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, Wells Fargo & Company cut their target price on shares of Synopsys from $630.00 to $550.00 and set an “equal weight” rating for the company in a report on Wednesday, September 10th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $562.14.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.